StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/3076% below fair value
$0.42+0.03 (+8.06%)

Close on Nov 13, 2026Market cap $8.14MP/E –Yield –

Ensysce Biosciences statistics

65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 29, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$8.14M
$272.32M
Enterprise Value
-$21.86M
$146.23M
PS Ratio
1.32
3.66
PB Ratio
0.30
2.00
P/TBV Ratio
0.30
2.22

Enterprise valuationIndustry

EV / Sales
-3.53
2.57

Share statisticsIndustry

Shares Change (YoY)
441.1%
10.8%
Shares Change (QoQ)
19.9%
0.50%
Float
18M
49M
Shares Held by Insiders
6.20%
11.7%
Shares Held by Institutions
4.65%
56.4%

Short sellingIndustry

Short Interest
88,607
–
Short Interest Change
-70.8%
-0.80%
Short % of Float
0.49%
9.01%
Short % of Shares Outstanding
0.46%
6.30%
Days to Cover
1.00
5.15

Stock price statisticsIndustry

52-Week High
$2.17
–
52-Week Low
$0.23
–
20-Day Moving Average
$0.42
–
50-Day Moving Average
$0.45
–
200-Day Moving Average
$0.41
–
Average True Range (14)
$0.05
–
Price Change (1 Week)
27.3%
-1.15%
Price Change (1 Month)
-30.0%
-4.87%
Price Change (3 Months)
11.1%
-21.0%
Price Change (6 Months)
49.4%
-20.6%
Price Change (YTD)
-54.5%
-23.6%
Price Change (1 Year)
-79.7%
-22.4%
Price Change (3 Years)
-96.7%
-29.5%
Price Change (5 Years)
-100.0%
-77.9%
Average Volume (10 Days)
343,970
–
Average Volume (20 Days)
296,234
–
Average Volume (90 Days)
10M
–
Relative Volume
0.04
0.70
Relative Strength Index (14)
50.1
43.4
Volatility (1 Year)
136.3%
80.1%
Beta (5 Years)
2.58
1.07

MarginsIndustry

Operating Margin
-1477.0%
-38.7%
EBITDA Margin
-1477.0%
-27.7%

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-337.2%
-37.9%

Financial positionIndustry

Current Ratio
8.02
3.30
Quick Ratio
7.72
2.39
Interest Coverage
-7157.58
-6.35

GrowthIndustry

Revenue Growth (YoY)
37.9%
6.82%
Revenue Growth (3Y CAGR)
26.2%
2.25%
Revenue Growth (5Y CAGR)
5.21%
6.41%

EfficiencyIndustry

Asset Turnover
0.36
0.40
Revenue Per Employee
$773.66K
$429.29K
Employee Count
8
74
WACC
17.6%
10.2%

Income statement (TTM)Industry

Revenue
$6.19M
$66.37M
Operating Income
-$91.42M
-$21.37M
EBITDA
-$91.42M
-$17.21M
EPS (Diluted)
-$5.98
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$29.67M
$17.76M
Net Cash Per Share
$1.52
$0.80
Equity (Book Value)
$27.44M
$53.89M
Book Value Per Share
$1.41
$1.50
Tangible Book Value
$27.44M
$27.13M
Working Capital
$26.96M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$8.39M
-$12.38M

Taxes and interestIndustry

Interest Expense
$12.77K
$2.90M

Scores and fair valueIndustry

Altman Z-Score
-17.54
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodENSCS&P 500DifferenceENSC per yearS&P 500 per year
1 month-26.9%-3.0%−23.9 pts
3 months+20.1%-2.8%+22.8 pts
Year to date-54.5%+11.5%−66.0 pts
1 year-79.8%+13.5%−93.2 pts
3 years-96.7%+77.7%−174.4 pts-67.8%+21.1%
5 years-100.0%+72.6%−172.6 pts-86.1%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ENSC shares were sold short on Oct 30, 2026, down 70.8% from the previous report, or 0.49% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 26.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202688,607-70.8%264,7851.0
Oct 15, 2026303,956-71.9%804,7371.0
Sep 30, 20261,080,946-10.4%322,6643.4
Sep 15, 20261,205,824-15.5%690,4531.8
Aug 31, 20261,426,883+25.1%1,233,0431.2
Aug 14, 20261,140,145+496.0%84,955,9121.0
Jul 31, 2026191,291-52.6%244,5821.0
Jul 15, 2026403,334+121.2%2,235,7511.0
Jun 30, 2026182,353-49.9%1,052,9071.0
Jun 15, 2026364,278+619.9%1,391,7221.0
May 29, 202650,601-93.8%874,3101.0
May 15, 2026814,605+1444.9%8,665,0671.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?